Image 3
Image 4
Image 2
Image 5
Image 1
focusing on the patient

Welcome to
OLM Innovations

OLM Innovations is committed to supporting the development of new and innovative diagnostic products with clear clinical benefits.

We will guide the process from inception to commercialisation, using our international network of specialists and decision makers in the medical sector to help give products the best possible chance of success.

Find out more about OLM innovations here.

Company News

rss_button
Journal of Infection publishes Martin Hoenigl paper
26/04/2013

Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients.

Journal of Clinical Microbiology publishes Lewis White paper
26/04/2013

Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a Novel Lateral-Flow Device for Diagnosis of Invasive Aspergillosis

Visit the news archive

Industry News

rss_button
Helvolic acid attenuates osteoclast formation and function via suppressing RANKL-induced NFATc1 activation.
22/10/2018

Related Articles Helvolic acid attenuates osteoclast formation and function via suppressing

Fulminant mulch pneumonitis in a previously healthy child.
22/10/2018

Related Articles Fulminant mulch pneumonitis in a previously healthy child.

Tebuconazole induces triazole-resistance in Aspergillus fumigatus in liquid medium and soil.
22/10/2018

Related Articles Tebuconazole induces triazole-resistance in Aspergillus fumigatus in liquid

Visit the news archive